Aurobindo Pharma Ltd.

AUROPHARMA Share PricePharmaceuticals & Drugs

₹1,217.6

-5.5 (-0.4%)

As on December 5, 2025

Exchange Scrips: BSE524804NSEAUROPHARMAISININE406A01037

Market Cap ₹ 70,736 Cr

P/E Ratio 20.29

Dividend Yield N/A

Performance

Market performance

Open1,225

High1,226.4

Volumes3,94,525

Prev1,217.6

Low1,209

As on2025-12-05

Historical performance

1 Year High1,356.2

3 Year High1,592

5 Year High1,592

1 Year Low1,010

3 Year Low397.2

5 Year Low397.2

Fundamentals

Company Valuation

Market Cap (₹Cr)

70,736

Face Value (₹)

P/E Ratio

20.29

Dividend Yield

N/A

Investment Returns

1 Year

-2.1%

3 Years

161.4%

5 Years

35.2%

10 Years

50.9%

Technicals

Indicators	Value	Signal
5-DMA	1,216.2	Bullish
10-DMA	1,217.29	Bullish
20-DMA	1,211.89	Bullish
50-DMA	1,149.14	Bullish
100-DMA	1,118.25	Bullish
200-DMA	1,135.07	Bullish

Shareholding Pattern

Field	Sep-2025	Jun-2025	Mar-2025	Dec-2024	Sep-2024
Promoters	14	14	14	14	14
Foreign Investors	1	1	1	1	1
Domestic Investors	13	13	13	13	13
Public Investors	247648	272194	269309	257948	248474
Government	---	1	1	1	1

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

Negative

Neutral

Positive

The stock has a PE ratio of 20.29.
3Y Stock Price CAGR of the stock is 38.4.
The stock has a beta of 1.1.
In the last financial year, the company had an EBITDA of ₹72046 Million.
The company generated revenue of ₹317237 Million in the previous financial year.

Aurobindo Pharma Ltd.

1217.6-5.5 (-0.4%)

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 982331.6

No. of Shares: 807 (Approx)

Performance:-1.8%

P/L: ₹-17668.4

Top Gainers